Literature DB >> 28453805

Pathological investigation of graft-related oesophageal fistula.

Masaki Yamamoto1, Hideaki Nishimori1, Mitsuko Iguchi2, Kazumasa Orihashi1.   

Abstract

Oesophageal fistulae after thoracic endovascular aneurysm repair (TEVAR) for thoracic aortic aneurysm (TAA) have been reported, although the causes are unknown. One hypothesis is that the structural configuration of the aortic aneurysm, as it protrudes towards the oesophagus, may affect oesophageal fistula formation. The pathological findings of an oesophageal fistula following TEVAR are reviewed here. This report presents the case of a 68-year-old man with a stent graft-related oesophageal fistula after TEVAR for TAA. The oesophageal fistula suddenly appeared on the 11th day after TEVAR, and oesophagectomy was performed, without stent graft extirpation. The pathological findings showed neutrophil infiltration from the adventitia to the mucosa and congestion in the capillaries of the oesophageal wall around the site of penetration and no bacterial infection. There have been reports with logical hypotheses about the causes of stent graft-related oesophageal fistulae. Our pathological findings support the theory that pressure necrosis or ischaemic insult by physical compression of a rigid thrombosed aneurysm may result in fistula formation. For descending aortic aneurysms that protrude toward the oesophagus, caution must be exercised to prevent oesophageal fistula formation after TEVAR.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Oesophageal fistulae; Stent graft; Thoracic aortic aneurysm

Mesh:

Year:  2017        PMID: 28453805     DOI: 10.1093/icvts/ivx003

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  1 in total

Review 1.  Risk Factors for Mortality in Patients with Aortoesophageal Fistula Related to Aortic Lesions.

Authors:  Shan Li; Feng Gao; Hai-Ou Hu; Jin Shi; Jie Zhang
Journal:  Gastroenterol Res Pract       Date:  2020-09-17       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.